Skip to main content
main-content

Zeitschrift

Cancer Immunology, Immunotherapy

Cancer Immunology, Immunotherapy 4/2010

Ausgabe 4/2010

Inhaltsverzeichnis ( 15 Artikel )

01.04.2010 | Review | Ausgabe 4/2010

Regulation of immunity and oncogenesis by the IRF transcription factor family

David Savitsky, Tomohiko Tamura, Hideyuki Yanai, Tadatsugu Taniguchi

01.04.2010 | Original Article | Ausgabe 4/2010

CD4+CD45RA+CXCR4+ lymphocytes are inversely associated with progression in stages I–III melanoma patients

Maria Napolitano, Alessandro Ottaiano, Francesca Mauro, Caterina Ieranò, Rocco Satriano, Roberto Pacelli, Renato Franco, Valentina De Angelis, Giuseppe Castello, Stefania Scala

01.04.2010 | Original Article | Ausgabe 4/2010

A B-cell lymphoma vaccine using a depot formulation of interleukin-2 induces potent antitumor immunity despite increased numbers of intratumoral regulatory T cells

Sofía Grille, Andreína Brugnini, Martha Nese, Esteban Corley, Frank W. Falkenberg, Daniela Lens, José A. Chabalgoity

01.04.2010 | Original Article | Ausgabe 4/2010

Association of HLA class I antigen abnormalities with disease progression and early recurrence in prostate cancer

Barbara Seliger, Robert Stoehr, Diana Handke, Anja Mueller, Soldano Ferrone, Bernd Wullich, Andrea Tannapfel, Ferdinand Hofstaedter, Arndt Hartmann

01.04.2010 | Original Article | Ausgabe 4/2010

Increase in tumor size following intratumoral injection of immunostimulatory CpG-containing oligonucleotides in a rat glioma model

Christian Ginzkey, Sven O. Eicker, Matthias Marget, Joerg Krause, Stephan Brecht, Manfred Westphal, Hans H. Hugo, H. M. Mehdorn, Joerg Steinmann, Wolfgang Hamel

01.04.2010 | Original Article | Ausgabe 4/2010

Phase III, randomised, multicentre trial of maintenance immunotherapy with low-dose interleukin-2 and interferon-α for metastatic renal cell cancer

Rodolfo Passalacqua, Carlo Buzio, Sebastiano Buti, Camillo Porta, Roberto Labianca, Debora Pezzuolo, Roberta Camisa, Roberto Sabbatini, Luigi Benecchi, Caterina Messina, Rita Cengarle, Augusto Vaglio, Matteo Dalla Chiesa, Gianluca Tomasello, Caterina Caminiti

01.04.2010 | Original Article | Ausgabe 4/2010

Direct discovery and validation of a peptide/MHC epitope expressed in primary human breast cancer cells using a TCRm monoclonal antibody with profound antitumor properties

Bhavna Verma, Oriana E. Hawkins, Francisca A. Neethling, Shannon L. Caseltine, Sherly R. Largo, William H. Hildebrand, Jon A. Weidanz

01.04.2010 | Original Article | Ausgabe 4/2010

FTY720 and SEW2871 reverse the inhibitory effect of S1P on natural killer cell mediated lysis of K562 tumor cells and dendritic cells but not on cytokine release

Johannes Rolin, Kristin L. Sand, Eirunn Knudsen, Azzam A. Maghazachi

01.04.2010 | Original Article | Ausgabe 4/2010

Type I interferons inhibit the generation of tumor-associated macrophages

Lance U’Ren, Amanda Guth, Debra Kamstock, Steven Dow

01.04.2010 | Original Article | Ausgabe 4/2010

Homeostasis of peripheral FoxP3+ CD4+ regulatory T cells in patients with early and late stage breast cancer

Andrew J. Rech, Rosemarie Mick, David E. Kaplan, Kyong-Mi Chang, Susan M. Domchek, Robert H. Vonderheide

01.04.2010 | Original Article | Ausgabe 4/2010 Open Access

Performance of serum-supplemented and serum-free media in IFNγ Elispot Assays for human T cells

Sylvia Janetzki, L. Price, C. M. Britten, S. H. van der Burg, J. Caterini, J. R. Currier, G. Ferrari, C. Gouttefangeas, P. Hayes, E. Kaempgen, V. Lennerz, K. Nihlmark, V. Souza, A. Hoos

01.04.2010 | Original Article | Ausgabe 4/2010 Open Access

Serum is not required for ex vivo IFN-γ ELISPOT: a collaborative study of different protocols from the European CIMT Immunoguiding Program

A. Mander, C. Gouttefangeas, C. Ottensmeier, M. J. P. Welters, L. Low, S. H. van der Burg, C. M. Britten

01.04.2010 | Short Communication | Ausgabe 4/2010

Effective adoptive therapy of tap-deficient lymphoma using diverse high avidity alloreactive T cells

Zoran Popmihajlov, Fabio R. Santori, Daniel Gebreselassie, Anthony D. Sandler, Stanislav Vukmanovic

01.04.2010 | Meeting Report | Ausgabe 4/2010

ESCII–PIVAC meeting “Recent advances in cancer immunotherapy with an emphasis on cancer vaccines” held in Athens, 9–11 October 2008

Viktor Umansky, Barbara-ann Guinn

01.04.2010 | Erratum | Ausgabe 4/2010

Erratum to: A humanized anti-osteopontin antibody inhibits breast cancer growth and metastasis in vivo

Jianxin Dai, Bohua Li, Jinping Shi, Ling Peng, Dapeng Zhang, Weizhu Qian, Sheng Hou, Lei Zhao, Jie Gao, Zhiguo Cao, Jian Zhao, Hao Wang, Yajun Guo

Aktuelle Ausgaben

Neu im Fachgebiet Onkologie

Mail Icon II Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Onkologie und bleiben Sie gut informiert – ganz bequem per eMail.

Bildnachweise